IMMURON
Immuron Ltd is a publicly listed Australian bio pharmaceutical Microbiome company focused on oral immunotherapy using polyclonal antibody products for humans. Immuron is a uniquely positioned company developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis.
IMMURON
Industry:
Biopharma Biotechnology
Founded:
1994-01-01
Address:
Armadale, Victoria, Australia
Country:
Australia
Website Url:
http://www.immuron.com
Total Employee:
11+
Status:
Active
Contact:
+610398245254
Email Addresses:
[email protected]
Total Funding:
27.5 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Cloudflare DNS Amazon Sydney Region Sophos
Similar Organizations
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Current Employees Featured
Stock Details
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Immuron
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-06 | Immuron appoints Mr. Steven Lydeamore as Chief Executive Officer |
Official Site Inspections
http://www.immuron.com
- Host name: 172.67.136.207
- IP address: 172.67.136.207
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Immuron"
Immuron - Crunchbase Company Profile & Funding
Immuron may be growing as evidenced by the company achieving record sales for its product Travelan. The reports indicate that Immuron has seen record half-yearly sales for Travelan, which suggests a significant increase in revenue.See details»
Imunon โ Immunotherapy Company
Imunon is developing new medicines that harness the building blocks of life to work in harmony with the bodyโs immune system. Imunon creates proprietary immunology and DNA-based โฆSee details»
Immuron - Wikipedia
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited. Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. . The company specialises in nutraceutical, pharmaceutical anโฆSee details»
Immuron Investor Centre
Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is a commercial and clinical stage publicly listed Australian biopharmaceutical company with a proprietary technology platform focused on the โฆSee details»
Celsion Corporation Announces Company Name Change to โฆ
Sep 19, 2022 New name reflects the evolution of the Companyโs business focus and its commitment to immunotherapies and vaccines LAWRENCEVILLE, N.J., Sept. 19, 2022 โฆSee details»
Immuron Limited - AnnualReports.com
Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is a microbiome company focused on developing and commercialising oral immunotherapeutics for the treatment of many gut mediated diseases.See details»
Celsion Corporation Announces Company Name Change to โฆ
New name reflects the evolution of the Companyโs business focus and its commitment to immunotherapies and vaccines. LAWRENCEVILLE, N.J., Sept. 19, 2022 (GLOBE โฆSee details»
Immuron Limited (IMRN) Company Profile & Overview - Stock โฆ
6 days ago Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, โฆSee details»
Immuron Limited (IMRN) Company Profile & Facts - Yahoo Finance
See the company profile for Immuron Limited (IMRN) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives โฆSee details»
Immuron Ltd, IMC:ASX profile - FT.com - Financial Times
Nov 22, 2024 Immuron Ltd (IMC:ASX) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Immuron - LinkedIn
Immuron | 1,304 followers on LinkedIn. Immuron is focused on developing and commercialising products for gut mediated diseases. | Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is an โฆSee details»
Product Pipeline - immuron1
Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is a commercial and clinical stage publicly listed Australian biopharmaceutical company with a proprietary technology platform focused on the โฆSee details»
Homepage โ Immunome
Immunome is proud to be an Equal Employment Opportunity employer. We do not discriminate based upon race, religion, color, national origin, gender (including pregnancy, childbirth, or โฆSee details»
Immuron Limited (IMRN) Stock Price, Quote & News - Stock Analysis
2 days ago About IMRN. Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United โฆSee details»
Immuron Clinical Trials Update - GlobeNewswire
Dec 22, 2023 About Immuron Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercializing orally delivered โฆSee details»
Immuron Announces Positive Results Support Travelan® progress โฆ
MELBOURNE, Australia, March 07, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is โฆSee details»
ImmuOn Therapeutics, Ltd.
ImmuOn Therapeutics is founded by oversea returned scientists and is a fully integrated biopharma company. ImmuOn is one of the few biotech companies in China who first explored โฆSee details»
ImmuOn
้ๅขๅ ฌๅธ้พๆฅ๏ผๆฑ่ๆฌฃ็ๅ ็็ฉ็งๆๆ้ๅ ฌๅธ ็ๆๆๆ(C)ๆฑ่ๅฅๅฎ็็ฉ็งๆๅ ฌๅธ ๅฐๅ๏ผๆฑ่็ๅ้ๅธ้ๆกฅ้ซ็งๅไธๅญ12F ็ต่ฏ๏ผ86-513-55881566-801 ไผ ็๏ผ86-513-55881566-802 E โฆSee details»